Kiniksa Pharmaceuticals International KNSA
NASDAQ KNSA
$76.73 -4.06 (-5.03%)
At close: Oct 23, 2026 · 4:00 PM EDT

Kiniksa Pharmaceuticals International (KNSA) Sale and Maturity of Investments (2018 - 2026)

Updated

Analysis

Kiniksa Pharmaceuticals International (KNSA) Sale and Maturity of Investments (2018 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Sold (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn -
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 308.00 Mn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn -
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 1.30 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 136.00 Mn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 1.03 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 2.12 Bn
10 Kiniksa Pharmaceuticals International 11.97 Bn 10.71 Bn 220.03 Mn 36.70 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 36.70 Mn
Mar 31, 2026 145.66 Mn
Dec 31, 2025 40.78 Mn
Sep 30, 2025 84.08 Mn
Jun 30, 2025 30.61 Mn
Mar 31, 2025 44.03 Mn
Dec 31, 2024 87.48 Mn
Sep 30, 2024 48.13 Mn
Jun 30, 2024 42.44 Mn
Mar 31, 2024 61.88 Mn
Dec 31, 2023 45.98 Mn
Sep 30, 2023 40.83 Mn
Jun 30, 2023 73.70 Mn
Mar 31, 2023 15.00 Mn
Dec 31, 2022 20.10 Mn
Sep 30, 2022 36.40 Mn
Jun 30, 2022 63.80 Mn
Mar 31, 2022 7.50 Mn
Dec 31, 2021 10.00 Mn
Sep 30, 2021 47.90 Mn
API Access

Kiniksa Pharmaceuticals International Sale and Maturity of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=KNSA&period=max&api_key=YOUR_API_KEY